Detalles de la búsqueda
1.
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study.
Br J Cancer
; 125(9): 1261-1269, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34493820
2.
Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS).
Hered Cancer Clin Pract
; 17: 3, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30675318
3.
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.
BMC Cancer
; 16: 135, 2016 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26906039
4.
Mammographic density and breast cancer in women from high risk families.
Breast Cancer Res
; 17: 93, 2015 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26163143
5.
Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers.
Breast Cancer Res Treat
; 148(2): 415-21, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25342642
6.
Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.
BMC Cancer
; 14: 779, 2014 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25342282
7.
Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing.
JCO Precis Oncol
; 8: e2300446, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38513169
8.
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer.
JAMA Netw Open
; 7(4): e247811, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38648056
9.
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients.
Eur Urol Oncol
; 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38429210
10.
Evaluation of patients with metastatic renal cell carcinoma after failure of first-line treatment.
Cancer Metastasis Rev
; 31 Suppl 1: S3-9, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22689342
11.
Prophylactic mastectomy and bilateral salpingo-oophorectomy in patients with breast cancer: a systematic review of postsurgical sexual function and menopausal hormone therapy symptom mitigation.
Sex Med Rev
; 12(1): 3-13, 2023 12 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37183167
12.
SEOM clinical guideline on heritable TP53-related cancer syndrome (2022).
Clin Transl Oncol
; 25(9): 2627-2633, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37133731
13.
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers.
Eur J Cancer
; 185: 105-118, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36972661
14.
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study.
Eur Urol Oncol
; 2023 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37838555
15.
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer.
Breast Cancer Res Treat
; 132(1): 307-15, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22052327
16.
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel.
Cancers (Basel)
; 14(19)2022 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36230681
17.
Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study.
Clin Genitourin Cancer
; 20(1): 25-34, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34789409
18.
Prevalence and Clinicopathological Characteristics of Moderate and High-Penetrance Genes in Non-BRCA1/2 Breast Cancer High-Risk Spanish Families.
J Pers Med
; 11(6)2021 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34204722
19.
Fertility and breast cancer: A literature review of counseling, preservation options and outcomes.
Crit Rev Oncol Hematol
; 166: 103461, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34461268
20.
Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens.
Breast Cancer Res Treat
; 120(1): 245-51, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19575291